pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Efficacy and safety of nebulized thiamphenicol glycinate atsetiltsisteinate in treatment of chronic diseases of the respiratory system

    Редакция | 2013, Original articles, Practical medicine 05 (13) Pulmonology. Antimicrobial therapy | 18 октября, 2013

    S.I. OVCHARENKO, V.A. KAPUSTINA
    I.M. Sechenov First Moscow State Medical University

    Ovcharenko Svetlana Ivanovna
    Doctor of Medical Science, Professor at the Department of Intermediate Level Therapy
    26 Olimpiyskiy ave., apt.235, Moscow 129272
    tel. 8-916-406-67-78, e-mail: [email protected]

    The article shows the results of treatment of 25 patients with exacerbations of chronic bronchitis and chronic obstructive lung disease with inhalations of combined antibiotic and mucolytic drug ―  thiamphenicol glycinate atsetiltsisteinate. The dynamics of clinical, functional and laboratory parameters of these patients is shown. The data regarding the efficacy and safety of using thiamphenicol glycinate atsetiltsisteinate for patients with acute chronic bronchitis and chronic obstructive lung disease are obtained.

    Key words: thiamphenicol glycinate atsetiltsisteinate, chronic bronchitis, chronic obstructive lung disease, exacerbation.

     

    REFERENCES

    1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009 (www. goldcopd.com).

    2. MacNee W., Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease // Am J Respir. Crit. Care Med. ― 1999. ― 160. ― S58-65.

    3. Repine J.E., Lankhorst I.L.M., Debacker W.A et al. Oxidative stress in chronic obstructive pulmonary disease // Am J Respir. Crit. Care Med. ― 1997. ― 156. ― Р. 341–57.

    4. Anthonisen N.R., Manfreda J., Warren C.P.W. et al. Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease // Ann. Intern. Med. ― 1987. ― 106. ― Р. 196-204.

    5. Rizzato G. Antibiotics for aerosol intake in respiratory infections: pole position for tiamfenicol // L’Internista J. ― 2001. ― 9. ― 120.

    6. Melillo G., Chiummariello A., Scala G. On the use of a new molecular combination of acetylcysteine with thiamphenicol glycinate in bronchopulmonary suppurations // G Ital Chemioter. ― 1966. ― 13 (1). ― Р. 156-160

    7. H. Bürgi. Mucolytic and antibiotic effect of a new compound in chronic bronchitis // Chemotherapy. ― 1975. ― 21 (3-4). ― Р. 167-174.

    8. Vysotiuk L, Hromova A. Fluimucyl-antibiotic IT: ability of antioxidant therapy for patients with acute attack of infectious chronic obstructive lung disease // Lik Sprava. ― 2006. ― (1-2). ― Р. 65-81.

    9. Grassi C., De Benedetto F. Recent clinical evidence of the efficacy and safety of thiamphenicol glycinate acetylcysteinate and thiamphenicol glycinate // J Chemother. ― 2002. ― 14 (3). ― Р. 279-284.

     

    Метки: chronic bronchitis, chronic obstructive lung disease, exacerbation, Practical medicine 05 (13) Pulmonology. Antimicrobial therapy, S.I. OVCHARENKO, thiamphenicol glycinate atsetiltsisteinate, V.A. KAPUSTINA

    ‹ Use of recombinant human erythropoietin for prevention of postoperative anemia in case of pulmonary tuberculosis Sex-age structure of population suffered acute exposure ›
    • rus Версия на русском языке


      usa English version site


      Findloupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©